Synthetic Biologics Short Interest Ratio and Short Volume

Synthetic Biologics (NYSEAMERICAN:SYN) Short Interest Frequently Asked Questions

What is Synthetic Biologics' current short interest?

Short interest is the volume of Synthetic Biologics shares that have been sold short but have not yet been covered or closed out. As of September 30th, investors have sold 12,200 shares of SYN short. 0.01% of Synthetic Biologics' shares are currently sold short. Learn More on Synthetic Biologics' current short interest.

What is a good short interest percentage for Synthetic Biologics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.01% of Synthetic Biologics' floating shares are currently sold short.

Is Synthetic Biologics' short interest increasing or decreasing?

Synthetic Biologics saw a drop in short interest in the month of September. As of September 30th, there was short interest totaling 12,200 shares, a drop of 97.4% from the previous total of 464,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Synthetic Biologics' float size?

Synthetic Biologics currently has issued a total of 132,043,000 shares. Some of Synthetic Biologics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Synthetic Biologics currently has a public float of 129,710,000 shares.

How does Synthetic Biologics' short interest compare to its competitors?

0.01% of Synthetic Biologics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Synthetic Biologics: RedHill Biopharma Ltd. (2.84%), Immunic, Inc. (5.42%), AVEO Pharmaceuticals, Inc. (6.34%), Inozyme Pharma, Inc. (2.07%), Larimar Therapeutics, Inc. (3.07%), Immunome, Inc. (3.08%), Flora Growth Corp. (1.43%), Corvus Pharmaceuticals, Inc. (10.90%), Mustang Bio, Inc. (8.62%), and Alzamend Neuro, Inc. (0.72%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: S&P Global Inc. ($7.35 billion), Advanced Micro Devices, Inc. ($6.43 billion), Charter Communications, Inc. ($5.68 billion), Wayfair Inc. ($4.48 billion), Uber Technologies, Inc. ($3.77 billion), Canadian Pacific Railway Limited ($3.73 billion), Palo Alto Networks, Inc. ($3.10 billion), Zoom Video Communications, Inc. ($2.87 billion), Match Group, Inc. ($2.83 billion), and DoorDash, Inc. ($2.54 billion). View all of the most shorted stocks.

What does it mean to sell short Synthetic Biologics stock?

Short selling SYN is an investing strategy that aims to generate trading profit from Synthetic Biologics as its price is falling. To short Synthetic Biologics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Synthetic Biologics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Synthetic Biologics?

A short squeeze for Synthetic Biologics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SYN, which in turn drives the price of the stock up even further.

How often is Synthetic Biologics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SYN, twice per month. The most recent reporting period available is September, 30 2021.